We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
Cap. Flow
+$28.6B
Cap. Flow %
52.81%
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782

Sector Composition

Rank Sector Weight
1 Technology 17.77%
2 Healthcare 17.47%
3 Financials 15.58%
4 Consumer Discretionary 12.3%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRCL
2751
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$528K ﹤0.01%
87,328
+17,022
+24% +$164K
SHG icon
2752
Shinhan Financial Group
SHG
$32.8B
$526K ﹤0.01%
17,023
-19,375
-53% -$622K
SHPW
2753
DELISTED
Shapeways Holdings, Inc. Common Stock
SHPW
$526K ﹤0.01%
+17,725
New +$832K
PROK icon
2754
ProKidney
PROK
$316M
$524K ﹤0.01%
53,028
YELL
2755
DELISTED
Yellow Corporation Common Stock
YELL
$524K ﹤0.01%
41,626
+27,115
+187% +$296K
NKGN
2756
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$523K ﹤0.01%
54,089
+3,552
+7% +$34.6K
LXFR icon
2757
Luxfer Holdings
LXFR
$456M
$522K ﹤0.01%
27,040
+8,281
+44% +$169K
XLK icon
2758
PUT
State Street Technology Select Sector SPDR ETF
XLK
$112B
$522K ﹤0.01%
6,000
SALM
2759
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$519K ﹤0.01%
+169,848
New +$572K
ARAY icon
2760
Accuray
ARAY
$29M
$517K ﹤0.01%
108,326
-384,795
-78% -$1.85M
LITB
2761
LightInTheBox
LITB
$54M
$517K ﹤0.01%
85,410
-24,634
-22% -$208K
UHAL icon
2762
U-Haul Holding Co
UHAL
$14.3B
$517K ﹤0.01%
7,120
-26,560
-79% -$1.91M
VSAT icon
2763
Viasat
VSAT
$10.2B
$517K ﹤0.01%
+11,602
New +$601K
YSG
2764
Yatsen Holding
YSG
$322M
$516K ﹤0.01%
+47,959
New +$672K
CRAI icon
2765
CRA International
CRAI
$1.16B
$513K ﹤0.01%
+5,496
New +$550K
LSI
2766
DELISTED
Life Storage, Inc.
LSI
$511K ﹤0.01%
+3,328
New +$445K
REVBW icon
2767
CALL
Revelation Biosciences Warrant
REVBW
$510K ﹤0.01%
+50,000
New +$30.6K
SLAB icon
2768
Silicon Laboratories
SLAB
$7.17B
$510K ﹤0.01%
2,475
-708
-22% -$130K
ME
2769
DELISTED
23andMe Holding Co
ME
$510K ﹤0.01%
+3,830
New +$707K
LSXMK
2770
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$510K ﹤0.01%
+12,945
New +$502K
VMACW
2771
CALL
DELISTED
Vistas Media Acquisition Company Inc. Warrant
VMACW
$509K ﹤0.01%
+50,000
New +$38.9K
NVO
2772
Novo Nordisk
NVO
$225B
$508K ﹤0.01%
9,078
-17,366
-66% -$941K
REVB icon
2773
Revelation Biosciences
REVB
$4.06M
0
SOXX icon
2774
iShares Semiconductor ETF
SOXX
$40.6B
$508K ﹤0.01%
2,808
-45,000
-94% -$7.55M
TRMD icon
2775
TORM
TRMD
$3.05B
$508K ﹤0.01%
63,782
-5,410
-8% -$43.2K

Similar funds

Marshall Wace's Q4 2021 Portfolio in Review

As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.

  • Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
  • Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
  • Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
  • Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
  • Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
  • Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
  • Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.